New research from UCL reveals alarming levels of tooth decay in adults in England, highlighting the need for improved dental care and public health initiatives.
A global survey by the International Diabetes Federation shows that 40 % of employees with diabetes face negative treatment at work, with many considering leaving their jobs due to stigma and lack of support.
A major trial led by the University of Bristol and North Bristol NHS Trust is exploring a panel of blood tests to detect dementia faster and more accurately across diverse UK populations.
Scientists at Osaka Metropolitan University have unlocked a new way to regenerate bone using fat-derived stem cells, successfully healing spinal fractures in rats.
Researchers at the University of Nottingham have used a lightweight, wearable OPM‑MEG brain scanner to uncover distinct brain‐function changes in people with Multiple Sclerosis, a non‑invasive advance that could improve diagnosis and tracking of disease progression.
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a new framework signalling a significant overhaul of how rare disease treatments are tested, approved, and delivered in the UK.
Every year on 29 October, World Psoriasis Day raises awareness of the 125 million people worldwide living with psoriasis and psoriatic arthritis (PsA).
Breakthrough research shows the brain doesn't drift into sleep gradually; it hits a sudden "tipping point." Discover how scientists pinpoint the second your brain shuts down each night.
A UK patient has become the first with multiple sclerosis (MS) to receive cutting-edge CAR T-cell therapy, as scientists test whether the one-time treatment can halt disease progression.
Last month, the UK Government published its long-awaited 10-Year Health Plan, with one of its three key shifts being the move from ‘analogue to digital’.
Researchers at UCL have developed a method to reduce MRI scan times for dementia diagnosis by two-thirds, potentially doubling daily scan capacity and improving access to early care.
University of Bristol researchers have discovered a VEGF-C gene therapy that protects the kidneys and may prevent serious complications in people with type 1 diabetes.
